166 related articles for article (PubMed ID: 19799647)
1. Mesenchymal stem cells modified to express lentivirus TNF-α Tumstatin(45-132) inhibit the growth of prostate cancer.
Zhang X; Xu W; Qian H; Zhu W; Zhang R
J Cell Mol Med; 2011 Feb; 15(2):433-44. PubMed ID: 19799647
[TBL] [Abstract][Full Text] [Related]
2. Immunoproapoptotic molecule scFv-Fdt-tBid modified mesenchymal stem cells for prostate cancer dual-targeted therapy.
Yan F; Li X; Li N; Zhang R; Wang Q; Ru Y; Hao X; Ni J; Wang H; Wu G
Cancer Lett; 2017 Aug; 402():32-42. PubMed ID: 28529067
[TBL] [Abstract][Full Text] [Related]
3. Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling.
Han I; Yun M; Kim EO; Kim B; Jung MH; Kim SH
Stem Cell Res Ther; 2014 Apr; 5(2):54. PubMed ID: 24739733
[TBL] [Abstract][Full Text] [Related]
4. Lemur Tyrosine Kinase-3 Suppresses Growth of Prostate Cancer Via the AKT and MAPK Signaling Pathways.
Sun P; Sun X; Zhao W; Ren M; Zhang C; Wang Z; Xu W
Cell Physiol Biochem; 2017; 42(6):2582-2592. PubMed ID: 28848113
[TBL] [Abstract][Full Text] [Related]
5. Lentivirus-modified human umbilical cord mesenchymal stem cells maintain their pluripotency.
Qian H; Zhang X; Xu W; Zhu W; Cao H; Chen Y; Xu X; Wang M; Xie Y; Sun J
Biotechnol Appl Biochem; 2010 Feb; 55(1):53-62. PubMed ID: 19961436
[TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism.
Crisostomo PR; Wang Y; Markel TA; Wang M; Lahm T; Meldrum DR
Am J Physiol Cell Physiol; 2008 Mar; 294(3):C675-82. PubMed ID: 18234850
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
[TBL] [Abstract][Full Text] [Related]
8. Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer.
Sung SY; Liao CH; Wu HP; Hsiao WC; Wu IH; Jinpu ; Yu ; Lin SH; Hsieh CL
PLoS One; 2013; 8(8):e71637. PubMed ID: 23977098
[TBL] [Abstract][Full Text] [Related]
9. Coumestrol Inhibits Proliferation and Migration of Prostate Cancer Cells by Regulating AKT, ERK1/2, and JNK MAPK Cell Signaling Cascades.
Lim W; Jeong M; Bazer FW; Song G
J Cell Physiol; 2017 Apr; 232(4):862-871. PubMed ID: 27431052
[TBL] [Abstract][Full Text] [Related]
10. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
[TBL] [Abstract][Full Text] [Related]
11. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
[TBL] [Abstract][Full Text] [Related]
12. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
[TBL] [Abstract][Full Text] [Related]
13. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells.
Wang X; Yang L; Huang F; Zhang Q; Liu S; Ma L; You Z
Immunol Lett; 2017 Apr; 184():7-14. PubMed ID: 28223102
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.
Yang X; Du J; Xu X; Xu C; Song W
J Immunol Res; 2014; 2014():318098. PubMed ID: 24971369
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model.
Mohr A; Lyons M; Deedigan L; Harte T; Shaw G; Howard L; Barry F; O'Brien T; Zwacka R
J Cell Mol Med; 2008 Dec; 12(6B):2628-43. PubMed ID: 18373740
[TBL] [Abstract][Full Text] [Related]
17. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts.
Zhu Y; Cheng M; Yang Z; Zeng CY; Chen J; Xie Y; Luo SW; Zhang KH; Zhou SF; Lu NH
Drug Des Devel Ther; 2014; 8():2449-62. PubMed ID: 25525335
[TBL] [Abstract][Full Text] [Related]
19. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
Shukla S; Gupta S
Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
[TBL] [Abstract][Full Text] [Related]
20. TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms.
Wang Y; Crisostomo PR; Wang M; Markel TA; Novotny NM; Meldrum DR
Am J Physiol Regul Integr Comp Physiol; 2008 Oct; 295(4):R1115-23. PubMed ID: 18685072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
